Integrated Treatment of Hepatitis C Virus Infection (INTRO-HCV)
Integrated Treatment of Hepatitis C Virus Infection Among Patients With Injecting Drug Abuse:a Randomised Controlled Trial (INTRO-HCV)
Sponsor: Bergen kommune
Listed as NCT03155906, this NA trial focuses on Hepatitis C, Chronic and Opioid Dependence, on Agonist Therapy and remains completed. Sponsored by Bergen kommune, it has been updated 11 times since 2017, reflecting substantial change activity. This study is part of the global effort to build evidence for infectious disease interventions.
Status Flow
Change History
11 versions recorded-
Oct 2025 — Present [monthly]
Completed NA
Status: Active Not Recruiting → Completed
-
Sep 2024 — Oct 2025 [monthly]
Active Not Recruiting NA
-
Jul 2024 — Sep 2024 [monthly]
Active Not Recruiting NA
-
Nov 2023 — Jul 2024 [monthly]
Active Not Recruiting NA
-
Sep 2022 — Nov 2023 [monthly]
Active Not Recruiting NA
▶ Show 6 earlier versions
-
Apr 2021 — Sep 2022 [monthly]
Active Not Recruiting NA
-
Jan 2021 — Apr 2021 [monthly]
Active Not Recruiting NA
-
Jul 2019 — Jan 2021 [monthly]
Active Not Recruiting NA
Status: Recruiting → Active Not Recruiting
-
Sep 2018 — Jul 2019 [monthly]
Recruiting NA
-
Jun 2018 — Sep 2018 [monthly]
Recruiting NA
-
Jun 2017 — Jun 2018 [monthly]
Recruiting NA
First recorded
May 2017
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Bergen kommune
- Folkehelseinstituttet
- Forskningsrådet
- Haukeland University Hospital
- Helse Stavanger HF
- Helse Vest
- University of Bergen
For direct contact, visit the study record on ClinicalTrials.gov .